Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Greenstreet Yvonne
Relationship:   Chief Executive Office...
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   86,188    

Indirect Shares

   407      
Direct Value   $11,053,212    

Indirect Value

   $59,992      
Total Shares   86,595      
Total Value   $11,113,204      


Moelis & Co $59,336 Pacira Pharmaceuticals, Inc. $398,470 Alnylam Pharmaceuticals Inc $10,595,407 Moelis & Co $59,336 Pacira Pharmaceuticals, Inc. $398,470 Alnylam Pharmaceuticals Inc $10,595,407
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    4    

     Stock price went up :
    0   
    1    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -26.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Moelis & Co MC Director 2018-11-14 1,059 2015-02-19 0    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Director 2022-06-08 13,247 2015-06-03 0    Premium*  
            Alnylam Pharmaceuticals Inc ALNY Chief Executive Office... 2024-03-01 71,882 2024-03-01 407    Premium*  
* Premium Members only  

Records found :    93         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2022-08-03 4 A $0.00 $0 D/D 13,095 26,997 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2022-08-04 4 D $189.76 $1,150,439 D/D (6,002) 20,995 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2023-04-26 4 A $0.00 $0 D/D 16,952 37,947 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2023-04-27 4 S $193.18 $1,481,811 D/D (7,615) 30,332 0 %
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2023-08-03 4 A $0.00 $0 D/D 8,941 39,273 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2023-08-04 4 S $184.70 $753,986 D/D (4,057) 35,216 0 %
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2024-02-15 4 A $0.00 $0 D/D 16,953 52,169 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2024-02-16 4 S $147.50 $1,040,885 D/D (7,030) 45,139 0 %
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2024-02-27 4 OE $0.00 $0 D/D 5,921 51,060 0 -
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2024-02-28 4 S $154.54 $455,357 D/D (2,932) 48,128 0 %
ALNY Alnylam Pharmaceuticals I... Chief Executive Officer   •       •      –    2024-03-01 4 A $0.00 $0 D/D 23,754 71,882 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2019-04-09 4 A $0.00 $0 I/I 49 357 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2019-07-11 4 A $0.00 $0 I/I 50 407 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2019-11-20 4 AS $105.00 $882,420 D/D (8,404) 1,916 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2019-11-20 4 OE $42.22 $354,817 D/D 8,404 10,320 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2019-12-12 4 D $120.61 $386,917 D/D (3,208) 6,208 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2019-12-12 4 A $0.00 $0 D/D 7,500 9,416 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2020-02-07 4 OE $42.22 $263,875 D/D 6,250 12,458 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2020-02-07 4 AS $123.90 $774,375 D/D (6,250) 6,208 0 %
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2020-02-10 4 OE $42.22 $236,432 D/D 5,600 11,808 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2020-02-10 4 AS $130.00 $1,285,960 D/D (9,892) 1,916 0 %
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2020-04-07 4 A $0.00 $0 D/D 5,417 7,333 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2020-04-07 4 D $104.75 $263,503 D/D (2,513) 4,820 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2020-05-05 4 OE $42.22 $329,780 D/D 7,811 12,631 0 -
ALNY Alnylam Pharmaceuticals I... Chief Operating Officer   •       –      –    2020-05-05 4 AS $140.00 $1,093,540 D/D (7,811) 4,820 0 %
  93  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us